Atazanavir 31722-0653
Product NDC
31722-0653- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 7, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA212278
Need to source Atazanavir? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Atazanavir Sulfate | 150 mg/1 |
Drug Class
Cytochrome P450 2C8 Inhibitors [MoA]Cytochrome P450 3A Inhibitors [MoA]Cytochrome P450 3A4 Inhibitors [MoA]
Packaging Options(3)
1000 CAPSULE in 1 BOTTLE (31722-653-10)
100 BLISTER PACK in 1 CARTON (31722-653-31) / 10 CAPSULE in 1 BLISTER PACK
60 CAPSULE in 1 BOTTLE (31722-653-60)